{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:11:46Z","timestamp":1785499906350,"version":"3.56.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974007 , 82000223"],"award-info":[{"award-number":["81974007 , 82000223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>TEMPI (telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting) syndrome is a rare and newly defined multisystemic disease, which belongs to \u201cmonoclonal gammopathy of clinical significances\u201d. Due to its rarity, the etiology, pathogenesis, and clinical features of this disease remain largely unknown. Owing to its hidden and diverse clinical manifestations, missed diagnosis and misdiagnosis are common. In recent years, as more patients (including three fatal cases) were identified, some special clinical manifestations other than the typical pentad of TEMPI syndrome have been reported. Meanwhile, several studies attempting to identify the pathogenesis of TEMPI syndrome were conducted. In this review, we summarize the reported clinical characteristics of TEMPI syndrome and discuss the current and potential treatment options for patients with TEMPI syndrome, including those with relapsed\/refractory disease. Furthermore, we provide an overview of current knowledge on the pathophysiology of TEMPI syndrome.<\/jats:p>","DOI":"10.3389\/fendo.2022.886961","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T14:53:54Z","timestamp":1652972034000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["TEMPI Syndrome: Update on Clinical Features, Management, and Pathogenesis"],"prefix":"10.3389","volume":"13","author":[{"given":"Jian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1106670","article-title":"The TEMPI Syndrome\u2013a Novel Multisystem Disease","volume":"365","author":"Sykes","year":"2011","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004216","article-title":"The TEMPI Syndrome","volume":"135","author":"Sykes","year":"2020","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1205806","article-title":"Complete and Partial Responses of the TEMPI Syndrome to Bortezomib","volume":"367","author":"Schroyens","year":"2012","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfs139","article-title":"A New Case of TEMPI Syndrome","volume":"5","author":"Mohammadi","year":"2012","journal-title":"Clin Kidney J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.07.004","article-title":"Subcutaneous Bortezomib for Treatment of TEMPI Syndrome","volume":"14","author":"Jasim","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1202649","article-title":"Bortezomib to Treat the TEMPI Syndrome","volume":"366","author":"Kwok","year":"2012","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr433","article-title":"Perirenal Fluid Collections and Monoclonal Gammopathy","volume":"27","author":"Viglietti","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1378\/chest.1701121","article-title":"Too Much Blood: A Case of the Newly Described TEMPI Syndrome","volume":"144","author":"Ryden","year":"2013","journal-title":"Chest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2014.117","article-title":"Bone Marrow Findings of the Newly Described TEMPI Syndrome: When Erythrocytosis and Plasma Cell Dyscrasia Coexist","volume":"28","author":"Rosado","year":"2015","journal-title":"Mod Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.298","article-title":"Long-Term Complete Clinical and Hematological Responses of the TEMPI Syndrome After Autologous Stem Cell Transplantation","volume":"29","author":"Kenderian","year":"2015","journal-title":"Leukemia"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13125","article-title":"Difficulties in Hematopoietic Progenitor Cell Collection From a Patient With TEMPI Syndrome and Severe Iatrogenic Iron Deficiency","volume":"55","author":"Belizaire","year":"2015","journal-title":"Transfusion"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2015.06.011","article-title":"Coexistence of Rheumatoid Arthritis and TEMPI Syndrome: New Insight in Microangiogenic-Related Diseases","volume":"83","author":"Pascart","year":"2016","journal-title":"Joint Bone Spine"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.065","article-title":"A Case of Atrophie Blanche in a Patient With TEMPI Syndrome","volume":"79","author":"Debbaneh","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-019-03761-4","article-title":"Relapsed Multiple Myeloma as TEMPI Syndrome With Good Response to Salvage Lenalidomide and Dexamethasone","volume":"98","author":"Liang","year":"2019","journal-title":"Ann Hematol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3547-19","article-title":"The First Case of TEMPI Syndrome in Japan","volume":"59","author":"Shizuku","year":"2020","journal-title":"Intern Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"A7234","DOI":"10.1164\/ajrccm-conference.2020.201.1_MeetingAbstracts.A7234","article-title":"Hunting for the Shunting: A Rare Case of Intrapulmonary Shunting Due to TEMPI Syndrome Causing Hypoxia","volume":"201","author":"Manek","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106441","article-title":"A Fatal Case of TEMPI Syndrome, Refractory to Proteasome Inhibitors and Autologous Stem Cell Transplantation","volume":"97","author":"Diral","year":"2020","journal-title":"Leuk Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.2668","article-title":"TEMPI Syndrome With Progressive Telangiectasias Associated With Pulmonary Deterioration","volume":"156","author":"Lor","year":"2020","journal-title":"JAMA Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112137-20200409-01144","article-title":"Case 528: Skin Pruritus-Polycythemia-M Proteinemia (in Chinese)","volume":"100","author":"Guo","year":"2020","journal-title":"Natl Med J China"},{"key":"B20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jdcr.2021.02.022","article-title":"Diffuse Telangiectasia: A Clue to the TEMPI Syndrome","volume":"10","author":"Ruan","year":"2021","journal-title":"JAAD Case Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112137-20200817-02405","article-title":"A Case of TEMPI Syndrome (in Chinese)","volume":"101","author":"Liu","year":"2021","journal-title":"Natl Med J China"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003783","article-title":"Whole-Genome Sequencing Suggests a Role of MIF in the Pathophysiology of TEMPI Syndrome","volume":"5","author":"Sun","year":"2021","journal-title":"Blood Adv"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17539","article-title":"Cutaneous Ulceration as Primary Presentation of TEMPI Syndrome","volume":"35","author":"Strobl","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1182\/blood.2021014393","article-title":"TEMPI Syndrome Associated With IgM Monoclonal Gammopathy","volume":"139","author":"Kubik","year":"2022","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2018.07.284","article-title":"TEMPI Syndrome: Erythrocytosis in Plasma Cell Dyscrasia","volume":"18","author":"Zhang","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcpc1004086","article-title":"Case Records of the Massachusetts General Hospital. Case 23-2010. A 49-Year-Old Man With Erythrocytosis, Perinephric Fluid Collections, and Renal Failure","volume":"363","author":"Bazari","year":"2010","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2018.12.013","article-title":"Erythropoietin in Tumor Angiogenesis","volume":"374","author":"Annese","year":"2019","journal-title":"Exp Cell Res"},{"key":"B28","article-title":"Diagnostic Value of Serum Erythropoietin Level in Patients With Absolute Erythrocytosis","volume":"89","author":"Mossuz","year":"2004","journal-title":"Haematologica"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine1962.28.396","article-title":"Secondary Polycythemia Associated With Multiple Myeloma","volume":"28","author":"Inase","year":"1989","journal-title":"Jpn J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8781721","article-title":"Concurrent Polycythemia of Undetermined Etiology and Smouldering Plasma Cell Myeloma","volume":"2018","author":"Katerji","year":"2018","journal-title":"Case Rep Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1159\/000328996","article-title":"JAK2 Mutation-Negative Secondary Erythrocytosis in Smoldering Plasma Cell Myeloma: A Case Study and Review of the Literature","volume":"126","author":"Lee","year":"2011","journal-title":"Acta Haematol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"bcr2016216686","DOI":"10.1136\/bcr-2016-216686","article-title":"Polycythaemia: An Unusual Presentation of Multiple Myeloma","volume":"2016","author":"Hutchison","year":"2016","journal-title":"BMJ Case Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1804415","article-title":"Complete Responses in the TEMPI Syndrome After Treatment With Daratumumab","volume":"378","author":"Sykes","year":"2018","journal-title":"N Engl J Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-120576","article-title":"Bortezomib Inhibits Tumor Adaptation to Hypoxia by Stimulating the FIH-Mediated Repression of Hypoxia-Inducible Factor-1","volume":"111","author":"Shin","year":"2008","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41571-020-0427-6","article-title":"CAR T Cell Therapies for Patients With Multiple Myeloma","volume":"18","author":"Mikkilineni","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516282","article-title":"Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma","volume":"374","author":"Moreau","year":"2016","journal-title":"N Engl J Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(19)30152-4","article-title":"Pomalidomide, Bortezomib, and Dexamethasone for Patients With Relapsed or Refractory Multiple Myeloma Previously Treated With Lenalidomide (OPTIMISMM): A Randomised, Open-Label, Phase 3 Trial","volume":"20","author":"Richardson","year":"2019","journal-title":"Lancet Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1805762","article-title":"Elotuzumab Plus Pomalidomide and Dexamethasone for Multiple Myeloma","volume":"379","author":"Dimopoulos","year":"2018","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.3390\/ijms22073471","article-title":"Pulmonary Vascular Complications in Hereditary Hemorrhagic Telangiectasia and the Underlying Pathophysiology","volume":"22","author":"Bofarid","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.11.013","article-title":"Detection of TGF-\u03b2 in Pleural Effusions for Diagnosis and Prognostic Stratification of Malignant Pleural Mesothelioma","volume":"139","author":"Stockhammer","year":"2020","journal-title":"Lung Cancer"},{"key":"B41","first-page":"1372","article-title":"Advances in TEMPI Syndrome: Molecular Genetic Characterization of a Novel Disease","volume":"32","author":"Rosado","year":"2019","journal-title":"Modern Pathol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.886961\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T14:54:01Z","timestamp":1652972041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.886961\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":41,"alternative-id":["10.3389\/fendo.2022.886961"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.886961","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"article-number":"886961"}}